Title
Category
Credits
Event date
Cost
  • Antidepressants
  • Anxiety
  • Depression
  • Diagnostic Tools
  • Substance Use Disorders
  • Suicide
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Identification of depression is crucial, as untreated depression is linked to functional impairment and suicide. Learn from an expert about how measurement-based care provides a way to improve the recognition of depression and comorbid conditions.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Finally, you can offer patients with tardive dyskinesia approved medications that reduce symptoms. In this CME, Dr Leslie Citrome reviews the evidence.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Diagnostic Tools
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Tardive dyskinesia must be detected early to minimize the risk of permanence. Dr Stephen Saklad provides a refresher in this brief CME activity.
  • Depression
  • Electroconvulsive Therapy
  • Geriatric Psychiatry
  • Psychotherapy
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
How many older adults receive electroconvulsive therapy (ECT) for treatment-resistant depression? Among those who receive ECT, how many finish the course? What factors might predict patients’ continuation of ECT? Explore these topics in this journal CME activity.
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Eating Disorders
  • Medical Conditions
  • Women’s Mental Health
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
InstructionsClick the red REGISTER button to pay the $10 fee and take the posttest. Click here to return to the JCP CME article.OverviewWhat characteristics affect patients’ risk for postpartum depression? In what time frame is the risk greatest? Dr Johansen and colleagues analyzed a large US cohort to answer these questions. Find their results in this CME journal article.
  • Depression
  • Obsessive-Compulsive and Related Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
First-line treatments for OCD include selective serotonin reuptake inhibitors and cognitive-behavioral therapy. But what do you do when patients do not respond to these or second-line strategies? In this journal CME activity, explore the option of deep brain stimulation.
  • Antidepressants
  • Anxiety
  • Anxiolytics
  • Depression
  • Women’s Mental Health
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
Is prenatal benzodiazepine use or concurrent use of an antidepressant associated with increased risk of congenital malformations? Read this CME for more.
  • Antidepressants
  • Antipsychotics
  • Bipolar Disorder
  • Child and Adolescent Psychiatry
  • Depression
  • Metabolic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
Little is known about increased metabolic syndrome (MetS) prevalence in adolescents and youth with bipolar disorder. Read this journal CME article for more.
  • Antidepressants
  • Cognition
  • Depression
  • Mood Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
What is the efficacy of antidepressants and other agents for treating cognitive impairment in adults with major depressive disorder? Review available research in this CME journal activity.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What should you rule out to diagnose tardive dyskinesia (TD)? How do treatment options differ? In this journal CME activity, Drs Citrome and Saklad team up to review the best clinical strategies.

Pages